AXQ Capital’s Ovid Therapeutics OVID Stock Holding History

AXQ Capital’s Portfolio OVID Stock Details OVID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-85,411	Closed	-$190K	–	1253
2026 Q1	$190K	Buy	+85,411	New	+$153K	0.02%	768

Other funds holding OVID

Jupiter Topco New York $245B AUM

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

AXQ Capital's OVID Position: Q2 2026 in Review

AXQ Capital sold out of Ovid Therapeutics (OVID) in Q2 2026, closing a stake of 85,411 shares — an estimated $190K sold.

AXQ Capital first reported a position in OVID in Q1 2026 and held it in 1 quarter. The position peaked at $190K in Q1 2026. 131 funds tracked by Wall St. Rank hold OVID as of Q2 2026.

AXQ Capital reported no remaining Ovid Therapeutics position as of Q2 2026 after selling out during the quarter.
AXQ Capital sold 85,411 Ovid Therapeutics shares in Q2 2026, an estimated $190K.
AXQ Capital first reported a position in Ovid Therapeutics in Q1 2026 and held it in 1 quarter.
AXQ Capital's Ovid Therapeutics position peaked at $190K in Q1 2026.
131 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.